Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-005707

CVP, Chief Financial Officer gave up 5,065 shares (to pay taxes)

  • CVP, Chief Financial Officer acquired 7,465 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ullem Scott B. CVP, Chief Financial Officer 2024-05-03 Shares withheld for taxes −634 $85.06 $53,928 18,440 D
Ullem Scott B. CVP, Chief Financial Officer 2024-05-04 Option exercise +7,465 25,905 D
Ullem Scott B. CVP, Chief Financial Officer 2024-05-04 Shares withheld for taxes −4,431 $85.25 $377,743 21,474 D
Derivatives
Ullem Scott B. CVP, Chief Financial Officer 2024-05-04 Option exercise · Performance Rights −7,465 0 D
Loading xslF345X05/doc4.xml…